Valero A, Molina J, Nuevo J, Simon S, et al. Economic consequences of the overuse of short-acting beta-adrenergic agonists (SABA) in the treatment of asthma in Spain. J Investig Allergol Clin Immunol 2021 Nov 26:0. doi: 10.18176/jiaci.0767.
PMID: 34825651